Search

Your search keyword '"Speake, Cate"' showing total 386 results

Search Constraints

Start Over You searched for: Author "Speake, Cate" Remove constraint Author: "Speake, Cate"
386 results on '"Speake, Cate"'

Search Results

1. Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency.

2. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

4. Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review

5. Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes

6. Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review.

7. Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling

8. Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment

9. Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes Autoimmunity.

10. Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study

11. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

15. Author Correction: Trimodal single-cell profiling reveals a novel pediatric CD8αα+ T cell subset and broad age-related molecular reprogramming across the T cell compartment

16. Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes

17. Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.

18. Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR

19. Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control

21. Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 Diabetes.

22. PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome.

26. Mediators of monocyte chemotaxis and matrix remodeling are associated with mortality and pulmonary fibroproliferation in patients with severe COVID-19.

27. Type 1 Diabetes in Acute Pancreatitis Consortium: From Concept to Reality

28. Assessing the Pathophysiology of Hyperglycemia in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium

29. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Type 1 Diabetes in Acute Pancreatitis Consortium

30. Evaluating the Immunopathogenesis of Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium

36. Autoreactive [CD8.sup.+] T cell exhaustion distinguishes subjects with slow type 1 diabetes progression

38. Proinflammatory islet antigen reactive CD4 T cells are linked with response to alefacept in type 1 diabetes

41. Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles.

43. Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell Workshop

44. Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study

45. Tri-modal single cell (TEA-seq) profiling reveals a novel, epigenetically distinct T cell subset in children and global molecular reprogramming across age

47. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity

48. OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody–Positive Individuals.

49. Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.

50. Precision Diagnostics: Using Islet Autoantibodies to Characterize Heterogeneity in Type 1 Diabetes

Catalog

Books, media, physical & digital resources